Adverse drug events associated with metreleptin administration: a real-world pharmacovigilance study from 2014 to 2024 using the FAERS database
This study provides critical insights into the TTO of ADEs related to metreleptin, informing safe clinical application and emphasizing the importance of monitoring potential side effects.
Authors
- Xuan Luo (ORCID: https://orcid.org/0000-0002-1934-9400)
- Junhao He (ORCID: https://orcid.org/0009-0004-9706-4314)
- Chenning Zhang (ORCID: https://orcid.org/0000-0002-3649-2428)
- Mo Sun (ORCID: https://orcid.org/0009-0000-7467-6490)
- Jie Liu (ORCID: https://orcid.org/0009-0006-5054-4550)
Institutions
- Hubei University of Medicine (CN)
- Georgia Institute of Technology (US)
- Chengdu Medical College (CN)
- Third People's Hospital of Chengdu (CN)
- Kanion Pharmaceutical (China) (CN)
Publication Details
- Journal
- Expert Opinion on Drug Safety
- Published
- 2024-12-19
- DOI
- https://doi.org/10.1080/14740338.2024.2444575
- Citations
- 1
- Primary Topic
- Computational Drug Discovery Methods
- Type
- article
- Field-Weighted Citation Impact
- 0.36